✦ LIBER ✦

Anti-obesity Effect of Dioscorea nipponica Makino with Lipase-inhibitory Activity in Rodents

✍ Scribed by KWON, Chong-Suk; SOHN, Ho Yong; KIM, Sung Hee; KIM, Ji Hyun; SON, Kun Ho; LEE, Jeong Soon; LIM, Jin Kyu; KIM, Jong-Sang

Book ID: 126589403
Publisher: Japan Science and Technology Information Aggregator, Electronic
Year: 2003
Tongue: English
Weight: 325 KB
Volume: 67
Category: Article
ISSN: 0916-8451
DOI: 10.1271/bbb.67.1451

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-obesity effects in rodents of dieta

Anti-obesity effects in rodents of dietary teasaponin, a lipase inhibitor

✍ Han, L-K; Kimura, Y; Kawashima, M; Takaku, T; Taniyama, T; Hayashi, T; Zheng, Y- 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 96 KB

In vitro investigation of the potential

In vitro investigation of the potential health benefits of wild Mediterranean dietary plants as anti-obesity agents with α -amylase and pancreatic lipase inhibitory activities

✍ Marrelli, Mariangela; Loizzo, Monica Rosa; Nicoletti, Marcello; Menichini, Franc 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB

Novel selective antagonist of the cannab

Novel selective antagonist of the cannabinoid CB1 receptor, MJ15, with prominent anti-obesity effect in rodent models

✍ Wei Chen; Huoling Tang; Hongying Liu; Long Long; Zehui Gong; Jianquan Zheng; Mug 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 925 KB

Anti-obesity effects of ginsenoside Rh2

Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte

✍ Jin-Taek Hwang; Soon-Hee Kim; Myoung-Su Lee; Sung Hee Kim; Hye-Jeong Yang; Min-J 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 970 KB

Comparison of the anti-diabetic effects

Comparison of the anti-diabetic effects of GIP- and GLP-1-receptor activation in obese diabetic (ob/ob) mice: studies with DPP IV resistant N-AcGIP and exendin(1–39)amide

✍ Nigel Irwin; Paula L. McClean; Roslyn S. Cassidy; Finbarr P. M. O'Harte; Brian D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

## Abstract ## Background The two major incretin hormones, glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1) are being actively explored as anti‐diabetic agents because they lower blood glucose through multiple mechanisms. The rapid inactivation of GIP and GLP‐